Tilray Brands Future Growth

Future criteria checks 0/6

Tilray Brands is forecast to grow earnings and revenue by 72% and 7.9% per annum respectively. EPS is expected to grow by 69.9% per annum. Return on equity is forecast to be -1% in 3 years.

Key information

72.0%

Earnings growth rate

69.9%

EPS growth rate

Pharmaceuticals earnings growth	24.0%
Revenue growth rate	7.9%
Future return on equity	-1.0%
Analyst coverage	Good
Last updated	15 Nov 2024

Recent future growth updates

Recent updates

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jul 31

Tilray Shows Some Nice Improvement In Q4

Jul 30

Tilray Should Be Cut From Your Portfolio

Jul 14

Why Bears Think Tilray Brands Will Continue To Dip

May 29

Tilray Takes A Step Forward

May 21

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

May 01

Tilray Could Break Down

Apr 07

Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Mar 27

Tilray: Big Opportunities Ahead In Germany And Alcohol Segment

Mar 12

Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Jan 25

Tilray Remains Stuck In Neutral

Jan 10

Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Dec 19

Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Oct 10

Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

Oct 06

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Sep 18

Earnings and Revenue Growth Forecasts

NasdaqGS:TLRY - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
5/31/2027	1,041	-9	N/A	113	4
5/31/2026	958	-75	15	51	10
5/31/2025	904	-89	10	-27	12
8/31/2024	812	-213	-82	-50	N/A
5/31/2024	789	-245	-60	-31	N/A
2/29/2024	743	-368	-50	-18	N/A
11/30/2023	700	-1,446	-45	-21	N/A
8/31/2023	651	-1,458	16	38	N/A
5/31/2023	627	-1,453	-13	8	N/A
2/28/2023	596	-1,792	-70	-56	N/A
11/30/2022	603	-578	-102	-84	N/A
8/31/2022	614	-501	-151	-130	N/A
5/31/2022	628	-477	-211	-177	N/A
2/28/2022	617	42	-182	-148	N/A
11/30/2021	589	-275	-134	-101	N/A
8/31/2021	564	-375	-123	-82	N/A
5/31/2021	513	-367	-84	-45	N/A
2/28/2021	468	-521	-109	-58	N/A
11/30/2020	462	-243	-182	-105	N/A
8/31/2020	426	-149	-221	-138	N/A
5/31/2020	405	-103	-199	-101	N/A
2/29/2020	387	22	-215	-104	N/A
11/30/2019	338	-63	-198	-78	N/A
8/31/2019	263	-16	-190	-49	N/A
5/31/2019	179	-25	-198	-42	N/A
2/28/2019	92	-28	-194	-33	N/A
11/30/2018	43	63	-211	-17	N/A
8/31/2018	34	27	-195	-12	N/A
5/31/2018	28	23	N/A	-4	N/A
2/28/2018	24	25	N/A	1	N/A
11/30/2017	20	18	N/A	3	N/A
8/31/2017	18	15	N/A	0	N/A
5/31/2017	15	3	N/A	4	N/A
2/28/2017	13	6	N/A	4	N/A
11/30/2016	11	2	N/A	2	N/A
8/31/2016	9	1	N/A	1	N/A
5/31/2016	6	0	N/A	-1	N/A
2/29/2016	5	-1	N/A	-2	N/A
11/30/2015	3	-3	N/A	-3	N/A
8/31/2015	1	-4	N/A	-3	N/A
5/31/2015	0	-5	N/A	-4	N/A
2/28/2015	0	-5	N/A	-4	N/A
11/30/2014	N/A	-3	N/A	-2	N/A
8/31/2014	N/A	-3	N/A	-2	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TLRY is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TLRY is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TLRY is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TLRY's revenue (7.9% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: TLRY's revenue (7.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TLRY is forecast to be unprofitable in 3 years.

Tilray Brands Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

No longer forecast to breakeven

No longer forecast to breakeven

Consensus estimates of losses per share improve by 13%

Forecast to breakeven in 2027

Consensus EPS estimates fall by 31%

Recent updates

New minor risk - Profitability

No longer forecast to breakeven

Tilray Brands Is Still Priced Too High

Tilray Brands, Inc. Announces Fall Craft Beer Lineup

Tilray: Another Weed In The Garden

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Tilray Q1 Preview: Germany Could Drive Earnings Surprise

Tilray Brands Launches Charlotte's Web CBD Gummies in Canada

Tilray Brands, Inc. to Report Q1, 2025 Results on Oct 10, 2024

Tilray Brands, Inc., Annual General Meeting, Nov 21, 2024

New minor risk - Profitability

No longer forecast to breakeven

Look For Tilray To Keep Declining

New minor risk - Shareholder dilution

Tilray Brands (NASDAQ:TLRY) Is Making Moderate Use Of Debt

Tilray Brands, Inc. (NasdaqGS:TLRY) completed the acquisition of Terrapin Beer Co and Atwater Brewing Co. and Hop Valley Brewing Co and Revolver Brewing, LLC from Molson Coors Beverage Company (NYSE:TAP).

Entrepreneurial Equity Partners, L.P. acquired Truss Beverage Co. from Tilray Brands, Inc. (NasdaqGS:TLRY).

Tilray Brands, Inc. Announces the Expansion of its Solei Cannabis Product Lineup

Consensus estimates of losses per share improve by 13%

Independent Director exercised options to buy US$260k worth of stock.

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 47% Below Their Intrinsic Value Estimate

New minor risk - Profitability

Full year 2024 earnings: EPS misses analyst expectations

Tilray Shows Some Nice Improvement In Q4

Tilray Brands, Inc. to Report Q4, 2024 Results on Jul 29, 2024

Tilray Should Be Cut From Your Portfolio

Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape Innovations

Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic Brews

Tilray Brands, Inc. Announces the Launch of 'Purple Churro,' by Redecan Cannabis

President exercised options to buy US$1.5m worth of stock.

Insufficient new directors

Tilray Brands, Inc. Announces Good Supply Launches 'Twisted' All-In-One Vape

Forecast to breakeven in 2027

Why Bears Think Tilray Brands Will Continue To Dip

Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’

Tilray Takes A Step Forward

Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million.

Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million.

Tilray Brands, Inc Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage

Tilray Brands, Inc.'s Subsidiary Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

Tilray Brands, Inc. Introduces New Signature 'Bud Squad' Products

Consensus EPS estimates fall by 31%

Price target decreased by 8.0% to US$2.37

No longer forecast to breakeven

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Tilray Could Break Down

Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use

Tilray Brands, Inc. to Report Q3, 2024 Results on Apr 09, 2024

Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Tilray Brands, Inc. Announces Redecan Cannabis Launches New Spring Lineup

Tilray Brands, Inc. Introduces New Naturally Flavoured CBG Infused Cannabis Beverages

Tilray: Big Opportunities Ahead In Germany And Alcohol Segment

Manitoba Harvest Hemp Foods Introduces Protein-Rich Breakfast Staples with New Superseed Instant Oatmeal

Tilray Brands, Inc. Announces the Latest Craft Flower Releases by Premium Cannabis Brand, Broken Coast

Tilray Brands, Inc. Debuts Two New Ready-To-Drink Cold Brew Tea Beverages by Its Premium Cannabis Wellness Brand, Solei

No longer forecast to breakeven

New minor risk - Share price stability

Tilray Brands, Inc. Shares its Cannabis Lineup for Sports Fans

Forecast to breakeven in 2026

Tilray Brands Unveils Craft Beer Locks for the Big Game

Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Tilray Brands, Inc. Unveils the Latest Additions to the Diamond Collection from Premium Cannabis Brand, RIFF

Consensus EPS estimates upgraded to US$0.23 loss

Consensus EPS estimates upgraded to US$0.23 loss

No longer forecast to breakeven

Tilray Remains Stuck In Neutral

Second quarter 2024 earnings released: US$0.07 loss per share (vs US$0.11 loss in 2Q 2023)

Tilray Brands, Inc. to Report Q2, 2024 Results on Jan 09, 2024

Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking